Lofexidine for Adults Undergoing Lumbar Spine Surgery

Status Completed

Clinical Trial Summary

The primary objective is to investigate the effects of lofexidine in adults undergoing opioid tapering prior to elective lumbar spine surgery.

Clinical Trial Description

In this clinical trial, an open label design will be used to facilitate opioid tapering during a 12-day period prior to elective spine surgery. The primary outcome measure of this study is the number of patients who achieve a 50% reduction in daily opioid dose at day 12. ;

Study Design

Related Conditions & MeSH terms

Opioid Withdrawal

Clinical Trial Details

NCT number	NCT04126083
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 4
Start date	September 1, 2019
Completion date	April 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04080037` - Assessing Opioid Care Practices Using CPV Patient Simulation Modules	N/A
Completed	`NCT04140955` - Opioid Tapering After Spine Surgery	N/A
Not yet recruiting	`NCT03813095` - Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction	Phase 2
Completed	`NCT01262092` - Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals	Phase 2
Completed	`NCT04075214` - Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal	N/A
Recruiting	`NCT04325659` - An Innovative Intervention for OUD Treatment	Phase 2/Phase 3
Withdrawn	`NCT03678792` - Comparison of Three Opioid Detoxification Treatment Regimens	Phase 3
Terminated	`NCT04162145` - BRIDGE Device for Treatment of Opioid Withdrawal	N/A
Completed	`NCT04238754` - Oral Cannabidiol for Opioid Withdrawal	Phase 1/Phase 2
Recruiting	`NCT05053503` - Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder	N/A
Recruiting	`NCT05555485` - Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain	N/A
Active, not recruiting	`NCT03485430` - Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up	N/A
Recruiting	`NCT05790551` - Suboxone Dispenser for OUD	N/A
Completed	`NCT03174067` - Buprenorphine in the Emergency Department	Phase 4
Completed	`NCT04731935` - Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal	N/A
Completed	`NCT04470050` - Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal	Phase 1/Phase 2
Not yet recruiting	`NCT06442566` - ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain	Phase 1/Phase 2
Recruiting	`NCT05307458` - Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
Completed	`NCT03789214` - Medical Management of Sleep Disturbance During Opioid Tapering	Phase 2
Recruiting	`NCT04759703` - Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD	Phase 2/Phase 3